Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
University of Gdansk's International Centre for Cancer Vaccine Science (ICCVS) invites a PhD student to work on labeling NRF2 after electrophilic activation, exploring transcription factor variants and their regulation.
The project is funded by the National Science Centre (Poland) within the Sonata programme, under grant UMO-2021/43/D/NZ1/02059. A scholarship contract for 4 months provides 5,000 PLN monthly, and applicants must be a PhD student at a Polish university with excellent English.
Organisation/Company University of Gdansk Department International Centre for Cancer Vaccine Science Research Field Chemistry Technology » Biotechnology Researcher Profile First Stage Researcher (R1) Positions PhD Positions Application Deadline 8 Oct 2026 - 23:59 (Europe/Warsaw) Country Poland Type of Contract Temporary Job Status Full-time Hours Per Week 40 Offer Starting Date 1 Nov 2026 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No
We are looking for aPhD studentto perform labeling of newly translated NRF2 transcription factor upon electrophilic activation.
About the project
Project aims at identification of mRNA and protein variants of NRF2 transcription factor, their regulation and impact on stress response. The project is funded by the National Science Centre (Poland) within the programme SONATA under grant agreement no. UMO-2021/43/D/NZ1/02059.
About ICCVS
The International Centre for Cancer Vaccine Science (ICCVS) has been established in 2017 as a joint unit of the University of Gdańsk (UG) and the University of Edinburgh (UoE) within a project carried out within the International Research Agendas Programme of the Foundation for Polish Science funded from the European Regional Development Fund. The aim of ICCVS has been comprehensive research into development of novel diagnostic and prognostic markers and personalized anti-cancer therapies and vaccines, followed by their commercialization and implementation into clinical practice. ICCVS works on a range of national and international research projects concentrating on cancer biology and novel approaches to immunotherapies. The focus of the ICCVS is the development of personalized vaccine against non-small cell lung cancer (NSCLC). The approach is based on the use of cancer specific T cells that are selected by the special algorithm elaborated at ICCVS. The first in vitro and in vivo studies are very encouraging, and the team plans to start clinical trials in a few years from a prospective perspective.
Test and develop the protocol for nascent NRF2 detection with Click-iT chemistry in cell line models upon activation with electrophilic compounds.
Languages ENGLISH Level Excellent
Documents referring to items 1-5 should be prepared in English and sent merged as ONE pdf file.
Note: PhD student status at a Polish university is required.
Selection process
Additional comments
Number of offers available 1 Company/Institute International Centre for Cancer Vaccine Science, University of Gdansk Country Poland State/Province pomorskie City Gdańsk Postal Code 80-822 Street Kładki 24 Geofield